IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novelion Therapeutics Inc

CUSIP: 6700K2029 | 1 institutional holders

Quarters

Q2 2017Q1 2017Q4 2016
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2017

Bartlett & Co. LLC400
0.0% of portfolio›$4
StyleTurnoverLocationFiled
Bartlett & Co. LLC
400$40.0%N/AN/ACincinnati, OH2017-07-18